Attention-deficit hyperactivity disorder medical therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
|
Attention-deficit hyperactivity disorder Microchapters |
|
Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Template:Attention-deficit hyperactivity disorder On the Web |
|
American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder medical therapy |
|
FDA on Attention-deficit hyperactivity disorder medical therapy |
|
CDC on Attention-deficit hyperactivity disorder medical therapy |
|
Attention-deficit hyperactivity disorder medical therapy in the news |
|
Blogs on Attention-deficit hyperactivity disorder medical therapy |
|
Directions to Hospitals Treating Attention-deficit hyperactivity disorder |
|
Risk calculators and risk factors for Attention-deficit hyperactivity disorder medical therapy |
Overview
First line treatments for attention-deficit hyperactivity disorder include the use of stimulant medications. Medications such as atomoxetine may be a better alternative for patients with co-morbid substance abuse disorder. Behavioral modification with the use of medications has shown to have the most success in treating ADHD.
Treatment
Singularly, stimulant medication is the most efficient and cost effective method of treating ADHD. [1] [2] Over 200 controlled studies have shown that stimulant medication is an effective way to treat ADHD.[3][4] Methods of treatment usually involve some combination of medications, behavior modifications, life style changes, and counseling. Behavioral parent training, behavior therapy aimed at parents to help them understand ADHD has also shown short term benefits.[5] Omega-3 fatty acids, zinc and magnesium may have benefits with regard to ADHD symptoms.[6][7]
Comorbid disorders or substance abuse can make finding the proper diagnosis and the right overall treatment more costly and time-consuming. Psychosocial therapy is useful in treating some comorbid conditions.[8]
References
- ↑ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder http://www.aacap.org/galleries/PracticeParameters/JAACAP_ADHD_2007.pdf
- ↑ Jensen; et al. (2005). "Cost-Effectiveness of ADHD Treatments: Findings from the Multimodal Treatment Study of Children With ADHD". American Journal of Psychiatry. 162: 1628–1636 (Page:1633). doi:10.1176/appi.ajp.162.9.1628. PMID 16135621. Free full text
- ↑
- ↑ Barkley, Russell A. Treating Children and Adolescents with ADHD: An Overview of Empirically Based Treatments. ContinuingEdCourses.Net. Retrieved on 2007-08-13.
- ↑ Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder http://www.aacap.org/galleries/PracticeParameters/JAACAP_ADHD_2007.pdf
- ↑ Arnold LE, DiSilvestro RA (2005). "Zinc in attention-deficit/hyperactivity disorder". Journal of child and adolescent psychopharmacology. 15 (4): 619–27. doi:10.1089/cap.2005.15.619. PMID 16190793.
- ↑ Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR (2006). "Omega-3 fatty acid status in attention-deficit/hyperactivity disorder". Prostaglandins Leukot. Essent. Fatty Acids. 75 (4–5): 299–308. doi:10.1016/j.plefa.2006.07.004. PMID 16962757.
- ↑ Foster; et al. (2007). "Treatment of ADHD: Is More Complex Treatment Cost-Effective for More Complex Cases?". HSR: Health Services Research. 42 (1): 165–182 (Page:177). PMID 17355587.